Combustion Synthesis of SrAlO: Eu, Dy Phosphorescent Pigments for Glow-in-the-Dark Safety Markings.

This study deals with SrAlO: Eu, Dy phosphor pigments prepared by an optimized perchlorate-assisted combustion synthesis and tested for developing glow-in-the-dark safety markings. Recipes with different oxidizer/fuel ratios were designed to create an in-situ reducing-reaction atmosphere and promote Eu → Eu reduction, which is responsible for the specific long-lasting, green emission of the pigments. The obtained data proved the efficiency of glycine-rich mixtures (up to 200% glycine excess), which led to improved optical features, as compared to the reference stoichiometric sample.

Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis.

Expansion of circulating CD28- T-cells reminiscent of effector memory T-cells (T(EM)) has been reported in Wegener's granulomatosis (WG) recently. To investigate the role of T(EM) in WG, we analyzed the expression of the activating NK-receptor NKG2D and its ligand MIC on circulating T(EM) and in granulomatous lesions, respectively. NKG2D was anomalously expressed and preferentially detected on circulating CD4+CD28- T(EM) in WG.

Chlorpromazine induces apoptosis in activated human lymphoblasts: a mechanism supporting the induction of drug-induced lupus erythematosus?

Objective: Drug-induced lupus erythematosus is a serious side effect of certain medications, such as procainamide, quinidine, hydralazine, chlorpromazine, and isoniazid, the underlying pathogenesis of which is unresolved. In this study, we examined the influence of these drugs on the regulation of apoptosis, or programmed cell death, in quiescent and activated human lymphocytes. We also discuss the dysregulation of apoptosis as a pathogenetic factor in systemic lupus erythematosus.